Cargando…

The Surgeon and the Chemotherapy Programme in Malignant Disease

Detalles Bibliográficos
Autor principal:	Ravdin, I. S.
Formato:	Texto
Lenguaje:	English
Publicado:	1961
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2384407/ https://www.ncbi.nlm.nih.gov/pubmed/13739859

Ejemplares similares

Classical versus new prognostic factors for adjuvant treatment selection based on line software to estimate risk and benefit
por: Ravdin, PM
Publicado: (2005)

Combination in Malignant Diseases Chemotherapy
por: Fairley, G. Hamilton
Publicado: (1971)

STUDIES ON GALL BLADDER FUNCTION : VIII. THE FATE OF BILE PIGMENT AND CHOLESTEROL IN HEPATIC BILE SUBJECTED TO GALL BLADDER ACTIVITY
por: Riegel, Cecilia, et al.
Publicado: (1932)

FATE OF BILIRUBIN IN THE SMALL INTESTINE
por: Sackey, M. S., et al.
Publicado: (1934)

The Treatment of Malignant Disease by Regional Chemotherapy
por: Johnston, Ivan D. A.
Publicado: (1963)

Current practices of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the treatment of peritoneal surface malignancies: an international survey of oncologic surgeons
por: Yoo, Heon Jong, et al.
Publicado: (2018)

Plasma lipocalin-2 levels in the preclinical stage of Alzheimer's disease
por: Eruysal, Emily, et al.
Publicado: (2019)

Challenges of implementation of the preventive chemotherapy neglected tropical diseases programme in Ghana
por: Otoo, Desmond Dzidzornu, et al.
Publicado: (2023)

The surgeon and his tools-the case for a focused orthopaedic theatre induction programme
por: Kumar, AJ Shyam, et al.
Publicado: (2008)

Chemotherapy and Urological Malignancy
por: Read, G.
Publicado: (1983)

Cause of Death by Race and Ethnicity in Minnesota Before and During the COVID-19 Pandemic, 2019–2020
por: Blake, Madelyn J., et al.
Publicado: (2023)

Is a Surgeon-performed Ultrasound Good Enough in Diagnosing Thyroid Malignancy?
por: Mohanapriya, Gajarajan, et al.
Publicado: (2018)

Late-life depression with comorbid cognitive impairment and disability: nonpharmacological interventions
por: Wilkins, Victoria M, et al.
Publicado: (2010)

Chemotherapy of advanced malignant teratomas.
por: Newlands, E. S., et al.
Publicado: (1980)

Effects of preoperative chemotherapy on neuroblastoma with MYCN amplification: a surgeon’s perspective
por: Chui, Chanhon
Publicado: (2020)

Training programme in gasless laparoscopy for rural surgeons of India (TARGET study) - Observational feasibility study
por: Aruparayil, N., et al.
Publicado: (2021)

Lateral neck dissection surgeon volume and complications in head and neck endocrine malignancy
por: Campbell, James C., et al.
Publicado: (2023)

Dental Caries and Dental Anomalies in Children Undergoing Chemotherapy for Malignant Diseases
por: Talekar, Abhinav Liladhar, et al.
Publicado: (2022)

Malignant mast cell tumor of the thymus in an Royal College of Surgeons (RCS) rat
por: Terayama, Yui, et al.
Publicado: (2016)

Surgeon in the Crimea
por: Librach, I. M.
Publicado: (1969)

Surgeons’ Ability to Predict the Extent of Surgery Prior to Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy
por: Hentzen, Judith E. K. R., et al.
Publicado: (2020)

The Safety of Chemotherapy for Ovarian Malignancy during Pregnancy
por: Xing, Naidong, et al.
Publicado: (2022)

Trauma surgeon as thoracic surgeon
por: Feliciano, David V
Publicado: (2020)

The Impact of Chemotherapy after Pediatric Malignancy on Humoral Immunity to Vaccine-Preventable Diseases
por: Garonzi, Chiara, et al.
Publicado: (2020)

Temozolomide Chemotherapy in Patients with Recurrent Malignant Gliomas
por: Yang, Seung-Ho, et al.
Publicado: (2006)

Intraperitoneal Chemotherapy for Unresectable Peritoneal Surface Malignancies
por: Guchelaar, Niels A. D., et al.
Publicado: (2023)

＜Editors’ Choice＞ Learning curve of robotic lobectomy for lung malignancies by certified thoracic surgeons
por: Fukui, Takayuki, et al.
Publicado: (2021)

Crohn’s Disease: A Surgeon’s Perspective
por: Parray, Fazl Q., et al.
Publicado: (2011)

Redistribution of EZH2 promotes malignant phenotypes by rewiring developmental programmes
por: Mortimer, Thomas, et al.
Publicado: (2019)

Perioperative intraperitoneal chemotherapy for peritoneal surface malignancy
por: Yan, Tristan D, et al.
Publicado: (2006)

Malignant pericardial effusion: sclerotherapy or local chemotherapy?
por: Lestuzzi, C, et al.
Publicado: (2009)

Systemic adjuvant chemotherapy for advanced malignant ocular medulloepithelioma
por: Sheriff, Ibrahim H. N., et al.
Publicado: (2022)

Wirelessly Activated Nanotherapeutics for In Vivo Programmable Photodynamic‐Chemotherapy of Orthotopic Bladder Cancer
por: Sun, Bowen, et al.
Publicado: (2022)

Malignant Triton Tumor of the Sciatic Nerve as a Secondary Malignancy after Extended Field Radiotherapy and Chemotherapy of Hodgkin's Disease
por: Nitsche, Mirko, et al.
Publicado: (2014)

Histopathologic changes following neoadjuvant chemotherapy in various malignancies
por: Sethi, Divya, et al.
Publicado: (2012)

Chemotherapy-related infectious complications in patients with Hematologic malignancies
por: Rusu, Raluca-Ana, et al.
Publicado: (2018)

Study to Investigate the Knowledge of Rare Diseases among Dentists, Orthodontists, Periodontists, Oral Surgeons and Craniomaxillofacial Surgeons
por: Kühne, Annemarie, et al.
Publicado: (2020)

Speaking Up and Speaking Out: Gender Diversity in the Scientific Programme of the Royal Australasian College of Surgeons Annual Scientific Congress
por: Lai, Christine S., et al.
Publicado: (2021)

Current management of malignant bowel obstructions: a survey of acute care surgeons and surgical oncologists
por: Bleicher, Josh, et al.
Publicado: (2021)

Pulmonary Infectious Complications in Children with Hematologic Malignancies and Chemotherapy-Induced Neutropenia
por: Voulgaridou, Aikaterini, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_v11si8roprc303ia1o8cpl03l5